A new stem cell technique has been developed by scientists at the Memorial Sloan-Kettering Cancer Center that may lead to a quicker treatment for cancer and reduce chemotherapy dependence. Researchers were able to reprogram a donor's T-cells to fight cancer. "This means fewer side effects and secondly, because they stay in the body, they are 'living drugs' and once present move around and stop recurrences," said lead researcher Michel Sadelain.

Related Summaries